IRIS Accounts Production v24.3.2.46 10355088 Board of Directors 1.10.23 30.9.24 30.9.24 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh103550882023-09-30103550882024-09-30103550882023-10-012024-09-30103550882022-09-30103550882022-10-012023-09-30103550882023-09-3010355088ns15:EnglandWales2023-10-012024-09-3010355088ns14:PoundSterling2023-10-012024-09-3010355088ns10:Director12023-10-012024-09-3010355088ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3010355088ns10:Micro-entities2023-10-012024-09-3010355088ns10:AuditExempt-NoAccountantsReport2023-10-012024-09-3010355088ns10:FullAccounts2023-10-012024-09-3010355088ns5:CurrentFinancialInstruments2024-09-3010355088ns5:CurrentFinancialInstruments2023-09-3010355088ns5:Non-currentFinancialInstruments2024-09-3010355088ns5:Non-currentFinancialInstruments2023-09-3010355088ns10:RegisteredOffice2023-10-012024-09-30
REGISTERED NUMBER: 10355088 (England and Wales)












A-LAB SOLUTIONS LIMITED

Unaudited Financial Statements

for the Year Ended 30 September 2024






A-LAB SOLUTIONS LIMITED (REGISTERED NUMBER: 10355088)






Contents of the Financial Statements
for the Year Ended 30 September 2024




Page

Balance Sheet 1


A-LAB SOLUTIONS LIMITED (REGISTERED NUMBER: 10355088)

Balance Sheet
30 September 2024

30/9/24 30/9/23
£    £    £    £   
Called up share capital not paid - 190,000

Fixed assets 2,462 -

Current assets 50,780 231,647

Creditors
Amounts falling due within one year (39,987 ) (17,623 )
Net current assets 10,793 214,024
Total assets less current liabilities 13,255 404,024

Creditors
Amounts falling due after more than one year 120,000 -
Net (liabilities)/assets (106,745 ) 404,024

Capital and reserves (106,745 ) 404,024

Notes to the financial statements

1. Statutory information

A-Lab Solutions Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 10355088

Registered office: 40 Monkton Street
London
United Kingdom
SE11 4TX

2. Going concern

The directors will continue to adopt the going concern basis in preparing the financial statements which assumes that the company will continue in operation for the foreseeable future.

3. Average number of employees

The average number of employees during the year was 5 (2023 - 2 ) .

4. Directors' advances, credits and guarantees

During the year, the Company issued convertible loan notes ("CLNs") to the Co-Founders totalling 120,000 (CLN1 of £50,000 and CLN2 of £70,000, 2023: £0). The loan notes carry an interest rate of 4% per annum, (payable only if and when the loans are repaid) and mature on 14 May 2027 respectively 27 August 2027. The holders of the loan notes have the option to convert the outstanding principal and accrued interest into ordinary shares at a conversion price of £5 per share.

The loan notes are unsecured and are repayable in cash or convertible into equity, at the maturity date, or automatically upon the receipt by the Company of the full subscription amount due to it in connection with a Financing Round or the completion of a Sale or IPO. Accrued interest will only become payable if and when the Loans are repaid in accordance with this Agreement.

The loans will be sub-ordinated to all other liabilities of the Company.



A-LAB SOLUTIONS LIMITED (REGISTERED NUMBER: 10355088)

Balance Sheet - continued
30 September 2024


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 4 February 2025 and were signed on its behalf by:





L J M W Jacobs - Director